Top Story

TAVR improves QOL in patients at extreme surgical risk

March 5, 2015

Transcatheter aortic valve replacement yielded substantial improvements in disease-specific and health-related quality of life among patients with severe aortic stenosis at extreme surgical risk, according to new data from the CoreValve U.S. Extreme Risk Pivotal Trial.

The new analysis characterized health status outcomes after TAVR with a self-expanding prosthesis (CoreValve, Medtronic). Researchers assessed the health status of patients at baseline and at 1, 6 and 12 months after the procedure using the Kansas City Cardiomyopathy Questionnaire (KCCQ), the Short Form-12 and the EuroQol-5D surveys. Death, KCCQ overall summary score less than 45 or decline in KCCQ overall summary score of 10 points at 6 months indicated poor outcome after TAVR.

In the Journals

ADT increases risk for cardiovascular disease in men with prostate cancer

March 5, 2015
Patients with prostate cancer who received androgen-deprivation therapy demonstrated an increased risk for cardiovascular disease, according to study results.Men with a…
In the Journals

Female veterans undergoing cardiac catheterization have different characteristics than men

March 5, 2015
Female and male veterans undergoing cardiac catheterization present with different characteristics but similar long-term outcomes, according to new findings from the VA…
In the Journals

In patients with mitral regurgitation, surgery improves well-being

March 5, 2015
Compared with patients who do not undergo surgery, patients with organic mitral regurgitation who undergo surgery experience significant improvements in emotional and…

SCOTUS hears arguments over tax credits for subsidies under ACA

March 4, 2015
The U.S. Supreme Court today began hearing oral arguments in King vs. Burwell, a case that will determine whether the Internal Revenue Service may extend tax-credit…
More News Headlines »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
Meeting News Coverage Video
Healio ISC2015 Singhal th

VIDEO: Intra-arterial thrombectomy trial results indicate 'formula for success'

February 25, 2015
NASHVILLE, Tenn. — Aneesh B. Singhal, MD, vice chair of quality and safety at Massachusetts General Hospital…
More »
CME
Best of Lipid Forum III

Best of Lipid Forum III

This activity is supported by an educational grant from Amgen, Inc.

Appropriate therapies for various dyslipidemias remain a challenge for practitioners struggling to reduce residual risk…
More »
morganatic-roan